Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pupa, Serenella M."'
Autor:
Gabrielli, Federico, Salvi, Roberto, Garulli, Chiara, Kalogris, Cristina, Arima, Serena, Tardella, Luca, Monaci, Paolo, Pupa, Serenella M., Tagliabue, Elda, Montani, Maura, Quaglino, Elena, Stramucci, Lorenzo, Curcio, Claudia, Marchini, Cristina, Amici, Augusto
Publikováno v:
PLoS ONE; Mar2013, Vol. 8 Issue 3, p1-8, 8p
Autor:
Rossella Canese, Elda Tagliabue, Patrizia Nanni, Egidio Iorio, Daniele Morelli, Massimo Di Nicola, Simona Faraci, Patrizia Casalini, Lorenzo Castagnoli, Matteo Dugo, Claudio Vernieri, Ada Koschorke, Serenella M. Pupa
Publikováno v:
Journal of Cellular Physiology
Despite different molecular tumor profiles indicate that human epidermal growth factor receptor 2 (HER2) messenger RNA (mRNA) levels mirror HER2 addiction and trastuzumab benefit in HER2-positive breast cancer (BC), the identification of noninvasive
Autor:
Roberta Laranga, Lorena Landuzzi, Marianna L. Ianzano, Manuela Iezzi, Massimiliano Dall'Ora, Donatella Santini, Patrizia Nanni, Veronica Giusti, Enrico Di Oto, Mario Taffurelli, Giordano Nicoletti, Augusto Amici, Alessia Lamolinara, Serenella M. Pupa, Tania Balboni, Arianna Palladini, Claudio Ceccarelli, Sofia Asioli, Pier Luigi Lollini, Elda Tagliabue, Carla De Giovanni
Publikováno v:
Oncotarget
// Arianna Palladini 1, * , Giordano Nicoletti 2, * , Alessia Lamolinara 3, * , Massimiliano Dall’Ora 1, * , Tania Balboni 1 , Marianna L. Ianzano 1 , Roberta Laranga 1 , Lorena Landuzzi 2 , Veronica Giusti 1 , Claudio Ceccarelli 1, 4 , Donatella S
Autor:
Gianluca Tomasello, Giovanni Fucà, Silvia Giordano, Maria Antista, Federica Morano, Lorenzo Castagnoli, Serenella M. Pupa, Filippo de Braud, Giancarlo Pruneri, Chiara Costanza Volpi, Ferdinando De Vita, Michele Prisciandaro, Simona Corso, Giuseppe Aprile, Adele Busico, Maria Maddalena Laterza, Elena Ongaro, Salvatore Corallo, Maria Di Bartolomeo, Ambra Vittoria Gualeni, Elena Tamborini, Elisa Giommoni, Filippo Pietrantonio, Federica Perrone, Annunziata Gloghini, Chiara Cremolini, Alessandro Pellegrinelli
Purpose: Refining the selection of HER2-positive metastatic gastric cancer patient candidates for trastuzumab is a challenge of precision oncology. Preclinical studies have suggested several genomic mechanisms of primary resistance, leading to activa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::451763540a7d6b97cf3ddc86425c71f4
http://hdl.handle.net/11568/901565
http://hdl.handle.net/11568/901565